Evidence map›Paper›PMID 34214263›Full record

ArticleBiomedica : revista del Instituto Nacional de Salud2021

Fatal reversible cerebral vasoconstriction syndrome: An unusual presentation of a rare disease

Hernán Bayona, María Camila Valencia, Angélica Peña, Natalia Ramírez, Carlos Martínez

Abstract readCase Reports
In one paragraph

Article in Biomedica : revista del Instituto Nacional de Salud, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hernán BayonaFacultad de Medicina, Universidad de los Andes, Bogotá, D.C., Colombia. biomedica@ins.gov.co.
María Camila ValenciaFacultad de Medicina, Universidad de los Andes, Bogotá, D.C., Colombia. mcvm.362@gmail.com.
Angélica PeñaFacultad de Medicina, Universidad de los Andes, Bogotá, D.C., Colombia. biomedica@ins.gov.co.
Natalia RamírezFacultad de Medicina, Universidad de los Andes, Bogotá, D.C., Colombia. biomedica@ins.gov.co.
Carlos MartínezFacultad de Medicina, Universidad de los Andes, Bogotá, D.C., Colombia; Centro de ACV, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, D.C., Colombia. biomedica@ins.gov.co.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reversible cerebral vasoconstriction syndrome is a variable, segmental, and multifocal constriction of brain arteries, usually with a benign course. We describe the case of a 49-year-old woman who presented with headaches, visual symptoms, and seizures. Three days after admission, vasoconstriction areas were found in at least two vascular territories in two segments of the same arteries. The patient was admitted to the intensive care unit where her blood pressure was monitored and she received medical treatment. Surprisingly, the patient presented an unpredicted evolution in developing malignant cerebral edema on the seventh day after admission. She then suffered brain death and was taken to organ donation. A guided nervous system necropsy was later performed. The pathology discarded vasculitis and exhibited hemorrhage areas in the cerebral convexity. Herein, we discuss the most relevant aspects of cases with fulminant evolution reported in the literature. The reversible cerebral vasoconstriction syndrome is usually associated with fatal outcomes when patients exhibit focalization, their first neuroimaging typically shows disturbances, and a rapid clinical deterioration occurs. It is crucial to identify factors linked to poor prognosis and set intervention strategies and early prevention.

Indexed as

Cerebrovascular DisordersBrainFemaleHumansMiddle AgedNeuroimagingRare DiseasesVasoconstrictionbrain hemorrhagemortalityprognosisstrokevasoconstriction

Identifiers

PMID34214263
PMCPMC8372843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.